A Study of RO5045337 [RG7112] in Patients With Hematologic Neoplasms.

NCT00623870 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
116
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Hoffmann-La Roche